Cryochemical synthesis and antibacterial activity of hybrid nanocomposites based on dioxidine containing Ag and Cu nanoparticles incorporated in biopolymer cryostructurates

被引:0
作者
O. I. Vernaya
V. P. Shabatin
A. V. Nuzhdina
N. D. Zvukova
D. I. Khvatov
A. M. Semenov
V. I. Lozinskii
T. I. Shabatina
M. Ya. Melnikov
机构
[1] M. V. Lomonosov Moscow State University,Department of Chemistry
[2] M. V. Lomonosov Moscow State University,Department of Biology
[3] Russian Academy of Sciences,A. N. Nesmeyanov Institute of Organoelement Compound
来源
Russian Chemical Bulletin | 2017年 / 66卷
关键词
cryochemical synthesis; hybrid nanocomposites; dioxidine; silver and copper nanoparticles; alginate cryostructurates; antibacterial activity;
D O I
暂无
中图分类号
学科分类号
摘要
Cryochemical synthesis of hybrid nanocomposites based on the antibacterial drug, dioxidine, and metals (Ag, Cu) was performed. According to the data of H1 NMR, UV, and IR spectroscopy, low-temperature argon sorption, and transmission electron microscopy, met-als in these systems exist as Ag nanoparticles (with dimensions of 2—30 nm) or Cu nanoparti-cles (10—40 nm) involved in the bigger-sized particles of dioxidine with dimensions of 50—350 nm. These hybrid nanocomposites show the enhanced antibacterial activity towards the microbial cells Escherichia coli 52, Staphylococcus aureus 144, Mycobacterium cyaneum 98. The as-prepared drug nanocomposites are incorporated into spongy alginate cryostructurates. The feasibility of drug release from the biopolymer alginate carrier is proved and the related antibacterial activity is demonstrated.
引用
收藏
页码:2152 / 2156
页数:4
相关论文
共 69 条
[1]  
Panáek A.(2006)undefined J. Phys. Chem. B 110 16248-undefined
[2]  
Kvítek L.(2009)undefined Biotechn. Adv. 27 76-undefined
[3]  
Prucek R.(2010)undefined Ann. Microbiol. 60 75-undefined
[4]  
Kolá M.(2011)undefined Digest J. Nanomat. Biostruct. 6 1557-undefined
[5]  
Veeová R.(2013)undefined Int. J. Nanomed. 8 3187-undefined
[6]  
Pizúrová N.(2015)undefined J. Ind. Eng. Chem. 29 217-undefined
[7]  
Sharma V. K.(2007)undefined Nanotechn. Biol. Med. 3 168-undefined
[8]  
Nev ná T.(2010)undefined Nanotechn. Biol. Med. 6 103-undefined
[9]  
Zbo il R.(2002)undefined J. Karlsen, Drug Dev. Ind. Pharm. 28 621-undefined
[10]  
Rai M.(2013)undefined Appl. Mater. 6 1285-undefined